To expand our understanding of ARF6 function in cancer, we interrogated proteomic alterations induced by ARF6 activation and discovered that ARF6 dynamically regulates expression of the BRAF oncoprotein in melanoma and other cancer types, impacting tumor cell survival, including during MAPK targeted therapy. Here, BRAF is linked to melanoma.